Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
A recent survey shows heavy opposition to the proposal which could leave university licensing struggling, chill investment in startups, and threaten technology transfers.   13 October 2025
Stress, anxiety, burnout: ‘Real change needed’ in law
Big Pharma
Stress, anxiety, burnout: ‘Real change needed’ in law
A new report highlights widespread mental health issues among legal professionals, leading to poor wellbeing and career disillusionment.   10 October 2025
Gilead blocks HIV drug generics for more than 10 years
Americas
Gilead blocks HIV drug generics for more than 10 years
The pharma giant extends market exclusivity for a top-selling drug accounting for nearly half of its multi-billion-dollar sales.   9 October 2025
Europe
Bridging Brunel and AI: Why CIPA sees ‘a golden opportunity’
The promises and pitfalls of AI took centre stage at CIPA’s annual congress in Bristol this week, as Sarah Speight reports.   9 October 2025
Careers
Teva in-house counsel jumps to private practice
The hire brings experience managing global trademark, copyright, and domain portfolios, as well as prior in-house roles at Teva and Johnson & Johnson.   9 October 2025
Americas
Brazil’s patent shake-up: How pharma is handling a new reality
A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their IP strategies. Juliana Neves of Licks explains the key changes, upcoming reforms, and how companies can protect their portfolios effectively.   8 October 2025
Americas
Eli Lilly strikes AI drug discovery deal with US biotech
The pharma giant will share rights to new innovations with an AI-driven organoid platform designed to produce fully human antibodies in weeks.   7 October 2025
Big Pharma
Why AI drug discovery has an IP problem and what can be done
Can AI tools raise the bar for inventiveness? And when algorithms become as productive as living systems, will they make their own outputs unpatentable? Industry experts unpick AI drug discovery’s biggest issues.   6 October 2025
Careers
Blank Rome adds more patent attorneys in ‘strategic expansion’
The new recruits, who join the firm’s LA and NYC offices, bring specialisms in technology, commerce, pharma, agriculture and biotechnology.   6 October 2025
Careers
Simmons & Simmons patent litigator jumps ship
Life sciences specialist boosts its London office with an expert in small molecules, biologics, and gene therapy before UK courts, the UPC, and the EPO.   3 October 2025